Novo Nordisk A/S (NVO)
NYSE: NVO · Real-Time Price · USD
105.27
+2.64 (2.57%)
At close: Nov 20, 2024, 4:01 PM
102.56
-2.71 (-2.57%)
Pre-market: Nov 21, 2024, 5:49 AM EST
Novo Nordisk Employees
Novo Nordisk had 64,319 employees as of December 31, 2023. The number of employees increased by 9,134 or 16.55% compared to the previous year.
Employees
64,319
Change (1Y)
9,134
Growth (1Y)
16.55%
Revenue / Employee
$629,195
Profits / Employee
$220,258
Market Cap
462.22B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 64,319 | 9,134 | 16.55% |
Dec 31, 2022 | 55,185 | 6,707 | 13.84% |
Dec 31, 2021 | 48,478 | 3,155 | 6.96% |
Dec 31, 2020 | 45,323 | 2,065 | 4.77% |
Dec 31, 2019 | 43,258 | 56 | 0.13% |
Dec 31, 2018 | 43,202 | 520 | 1.22% |
Dec 31, 2017 | 42,682 | 711 | 1.69% |
Dec 31, 2016 | 41,971 | 1,333 | 3.28% |
Dec 31, 2015 | 40,638 | -319 | -0.78% |
Dec 31, 2014 | 40,957 | 2,521 | 6.56% |
Dec 31, 2013 | 38,436 | 3,705 | 10.67% |
Dec 31, 2012 | 34,731 | 2,099 | 6.43% |
Dec 31, 2011 | 32,632 | 2,149 | 7.05% |
Dec 31, 2010 | 30,483 | 1,154 | 3.93% |
Dec 31, 2009 | 29,329 | 2,754 | 10.36% |
Dec 31, 2008 | 26,575 | 1,059 | 4.15% |
Dec 31, 2007 | 25,516 | 1,903 | 8.06% |
Dec 31, 2006 | 23,613 | 1,153 | 5.13% |
Dec 31, 2005 | 22,460 | 1,735 | 8.37% |
Dec 31, 2004 | 20,725 | 1,969 | 10.50% |
Dec 31, 2003 | 18,756 | 751 | 4.17% |
Dec 31, 2002 | 18,005 | 1,864 | 11.55% |
Dec 31, 2001 | 16,141 | 2,389 | 17.37% |
Dec 31, 2000 | 13,752 | 1,758 | 14.66% |
Dec 31, 1999 | 11,994 | 345 | 2.96% |
Dec 31, 1998 | 11,649 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
AbbVie | 50,000 |
NVO News
- 1 day ago - Novo Nordisk Launches Wegovy Weight-Loss Drug in China - WSJ
- 1 day ago - Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons - GlobeNewsWire
- 2 days ago - Medicaid dominates coverage of Novo, Lilly weight-loss drugs - Fast Company
- 2 days ago - Novo Nordisk A/S - share repurchase programme - GlobeNewsWire
- 2 days ago - Novo Nordisk has launched obesity drug Wegovy in China - Reuters
- 4 days ago - Eli Lilly and Novo Want to Shake off Ozempic Copycats. Are They Ready To Meet Demand? - WSJ
- 5 days ago - Vaccine Maker Stocks Slump After RFK Jr. Nominated as HHS Head - Investopedia
- 5 days ago - RFK Jr. is not a fan of weight-loss drugs or vaccines. Stocks are tanking. - Market Watch